Navigation Links
Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting

- New Study Demonstrated the Clinical Potential of Peregrine's Unique Selective Anti-VEGF Antibodies, Which Were as Effective as Avastin(R) in Animal Cancer Models

TUSTIN, Calif., April 20, 2007 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing targeted monoclonal antibodies for the treatment of cancer and hepatitis C virus infection, today reported that data from multiple studies presented at the recent Centennial Annual Meeting of the American Association for Cancer Research (AACR) reinforced the versatility and broad anti-cancer potential of bavituximab, its clinical stage targeted anti- phospholipid (PS) monoclonal antibody; provided important new preclinical data confirming the potential anti-tumor efficacy of the company's selective VEGF inhibitors; provided validating data for its immunocytokine fusion proteins developed using the company's proprietary Vascular Targeting Agent (VTA) technology; and highlighted the clinical potential of Peregrine's earlier stage VTA and Vasopermeation Enhancement Agent (VEA) cancer platforms.

"We are extremely pleased with the quality, breadth and diversity of the studies we were selected to present at this historic Centennial AACR Annual Meeting," said Steven W. King, president and CEO of Peregrine. "We believe these studies are a testament to the scientific, medical and commercial potential of our core technology platforms. In particular, multiple studies presented data that support the broad anti-cancer utility of our anti-phospholipid platform, including our lead product candidate bavituximab, in a variety of applications and indications. Research confirming the versatility of our anti-PS antibodies in different anti-cancer combinations is especially encouraging. In addition, we also presented data that supports advancement of potentially important anti-cancer development programs based on our sele
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
4. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
5. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
11. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
(Date:8/28/2014)... 28, 2014 Nonin Medical, Inc., the inventor ... medical monitoring, today announced that the Food and Drug ... finger pulse oximeter for use in the ... into a telemedicine hub or kiosk through a USB ... pediatric to adult patients. The Model 3231 received EU ...
(Date:8/28/2014)... Oregon , August 28, 2014 ... Research titled, "DNA diagnostics Market (products, applications, techniques, ... Trends, Opportunities, Growth and Forecast, 2013 - 2020," ... reach $19 billion by 2020 registering a CAGR ... to provide accurate diagnosis and cost effectiveness over ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3
... 2011 Quest Diagnostics Incorporated (NYSE: DGX ... and services, today announced the CE mark and European ... test on the 3M™ Integrated Cycler.  The new test, ... technique to eliminate nucleic-acid sample extraction, a time-consuming process ...
... N.J., Nov. 1, 2011 MedAvante, Inc., the world,s ... of treatments for central nervous system (CNS) disorders, announced ... 2011 Fifty Fastest Growing Companies. NJBIZ, New ... 50 Fastest Growing Companies in celebration of New Jersey,s ...
Cached Medicine Technology:Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 2Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 3MedAvante Is One of NJ's Fastest Growing Companies 2
(Date:8/28/2014)... Skmen.com, one of the most popular suppliers of men’s ... long sleeve sweater dresses and launched a ... unveiled sweater outfits are available at discounted rates, up ... of fact, Skmen.com’s fashionable and quality items have greatly ... company’s experienced tailors are striving to make more incomparable ...
(Date:8/28/2014)... Recently, iFitDress.com, the distinguished wedding dress manufacturer and ... bridesmaid dresses . Included in the new range are ... them are provided at deeply discounted prices, from 22 ... fast and reliable delivery service. All clients from around ... short time. As is commonly noted, international customers have ...
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 ... Recovery Month throughout September. This month will be ... treatment and mental health services. Along with other ... Group is helping to spread the word about ... in 1989, honoring the work of treatment and ...
(Date:8/28/2014)... Arguments between parents may damage their relationships with their ... than 200 families were asked to make daily diary ... day, mothers and fathers rated the quality of their ... days when parents reported conflict and tension in their ... according to the study recently published in the ...
(Date:8/28/2014)... Arbor, MI (PRWEB) August 28, 2014 ... the nation’s leading intraoperative neurophysiology monitoring ("IONM") company, today ... to the position of Chief Executive Officer effective immediately. ... promoted to President and CFO in 2013 and has ... success. , “Bill’s efforts and achievements since joining ...
Breaking Medicine News(10 mins):Health News:Skmen.com: Bestselling Long Sleeve Sweater Dresses Are Offered Online Now 2Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:Biotronic NeuroNetwork Announces the Promotion of Bill Gecsey to CEO 2
... significantly expand its services, treating up to 24 patients ... ... April 17 Aurora St. Luke,s Medical Center,s,new hyperbaric chamber will ... improve its regional wound care,services., (Photo: http://www.newscom.com/cgi-bin/prnh/20080417/AQTH107 ), ...
... Family Research Council,Action applauds GOP Presidential candidate Senator ... University supporting the pro-life,platform of the Republican Party. ... possible running mates., FRC Action,s Senior Vice ... Senator McCain depict his support for life as ...
... WALTHAM, Mass., April 17 Inverness Medical,Innovations, Inc. ... rapid point-of-care,diagnostic products, today announced that it will ... 24, 2008. The Company will also host a,conference ... that date to,discuss these results and other corporate ...
... improving indoor air quality, COLUMBUS, Ohio, April 17 ... Heating and Cooling is encouraging,Central Ohioans to take steps ... free of harmful pollutants., National Indoor Comfort Week(R), ... relies, and honors the men and,women who keep those ...
... 19 million Americans living with chronic kidney disease (CKD) ... Recent studies have shown that a main source of ... blood phosphate. , Now researchers at Washington University ... high blood phosphate directly stimulates calcification of blood vessels ...
... 17 RESMED INC. (NYSE: RMD ),announced today that ... the third quarter of fiscal year 2008, ended March 31, ... Pacific Time and will,host a conference call to review its ... is scheduled to begin at 1:30 p.m. Pacific Time and,will ...
Cached Medicine News:Health News:Aurora St. Luke's Medical Center Installs the Country's Second-Largest Hyperbaric Chamber 2Health News:Aurora St. Luke's Medical Center Installs the Country's Second-Largest Hyperbaric Chamber 3Health News:Aurora St. Luke's Medical Center Installs the Country's Second-Largest Hyperbaric Chamber 4Health News:Aurora St. Luke's Medical Center Installs the Country's Second-Largest Hyperbaric Chamber 5Health News:Aurora St. Luke's Medical Center Installs the Country's Second-Largest Hyperbaric Chamber 6Health News:FRC Action Praises John McCain's Pro-Life Comments 2Health News:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results 2Health News:National Indoor Comfort Week - A Breath of Fresh Air for Allergy Sufferers 2Health News:Readily available treatment could help prevent heart disease in kidney patients 2Health News:Readily available treatment could help prevent heart disease in kidney patients 3Health News:ResMed to Webcast Third Quarter 2008 Earnings Conference Call 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: